A LinkedIn post from Cleerly highlights an upcoming webinar timed to Heart Month that focuses on women’s heart health and coronary artery disease. The event features preventative cardiologist Dr. Suzanne Steinbaum and is positioned around topics including sex-specific disease risk, the role of plaque, diagnostic limitations, and equity through data.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests Cleerly is emphasizing clinical education and engagement with cardiology professionals, particularly in under-addressed segments such as women’s cardiovascular risk. For investors, this type of activity may indicate ongoing efforts to build brand credibility, support adoption of its AI-enabled CT and digital health solutions, and align the platform with evidence-based practice in coronary care, which could support longer-term commercial traction.